Cases & Deals

City of Hope licenses cell-penetrating technology to affiliate of Sorrento Therapeutics

Clients City of Hope

Jones Day advised City of Hope in connection with an exclusive license granted to LA Cell, Inc., a company formed by Sorrento Therapeutics Inc. The newly formed company, LA Cell, will combine COH's cell-penetrating technology with Sorrento's fully human antibody library and immunotherapy expertise to enable the development of effective antibody therapies against crucial yet elusive intracellular targets. The total deal value exceeded $170 million and included the grant of equity to City of Hope as well as up front and milestone payments.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.